Cell cycle alterations and their relationship to proliferation in apocrine adenosis of the breast

Histopathology

Volumn 54, Issue 3, 2009, Pages 348-354

  Elayat, Ghada ^a,b   Selim, Abdel Ghani A ^a   Wells, Clive A ^b  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Apocrine adenosis; Breast; Cell cycle; Proliferation

Indexed keywords

CELL CYCLE PROTEIN; CELL CYCLE PROTEIN RB; CYCLIN A; CYCLIN D1; KI 67 ANTIGEN; PROTEIN ANTIBODY; PROTEIN P16; PROTEIN P27; UNCLASSIFIED DRUG;

ADULT; AGED; APOCRINE ADENOSIS; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST TUMOR; CELL CYCLE; CELL TYPE; CLINICAL ARTICLE; DOWN REGULATION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATORY CELL; PRIORITY JOURNAL;

ADULT; AGED; BREAST; BREAST NEOPLASMS; CELL CYCLE; CELL CYCLE PROTEINS; CELL PROLIFERATION; FEMALE; FIBROCYSTIC BREAST DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM INVASIVENESS;

EID: 60349091229     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2009.03223.x     Document Type: Article

References (27)

1. Eusebi V, Cassadei G, Bussolati G, Azzopardi J. Adenomyoepithelioma of the breast with a distinct type of apocrine adenosis. Histopathology 1987 11 305 315.
2. Kiaer H, Nielsen B, Paulsen S et al. Adenomyoepithelial adenosis and low grade malignant adenomyoeithelioma of the breast. Virchows Arch. A. Pathol. Anat. Histopathol. 1984 405 55 67.
3. Carter D, Rosen P. Atypical apocrine metaplasia in sclerosing lesions of the breast: a study of 51 patients. Mod. Pathol. 1991 4 1 5.
4. Raju U, Richard J, Zarbo J, Kubus J, Schultz D. The histologic spectrum of apocrine breast proliferations: a comparative study of morphology and DNA content by image analysis. Hum. Pathol. 1993 24 173 181.
5. Seidman J, Ashton M, Lefkowitz M. Atypical apocrine adenosis of the breast. A clinicopathologic study of 37 patients with 8.7 year follow up. Cancer 1996 77 2529 2537.
6. Simpson J, Page D, Dupont W. Apocrine adenosis - a mimic of mammary carcinoma. Am. J. Surg. Pathol. 1990 3 289 299.
7. Rosai J. Ackerman's surgical pathology, 8th edn. Philadelphia, PA : Mosby, Inc., 1996.
8. Endoh Y, Tamura G, Kato N, Motoyama T. Apocrine adenosis of the breast: clonal evidence of neoplasia. Histopathology 2001 38 221 224.
9. Wells C, McGregor I, Makunura C, Yeomans P, Davies J. Apocrine adenosis: a precursor of aggressive breast cancer? J. Clin. Pathol. 1995 48 737 742.
10. Selim A, El-Ayat G, Wells C. C-erbB2 oncoprotein expression, gene amplification and chromosome 17 aneusomy in apocrine adenosis of the breast. J. Pathol. 2000 191 138 142.
11. Selim A, Ryan A, El-Ayat G, Wells C. Loss of heterozygosity and allelic imbalance in apocrine adenosis of the breast. Cancer Detect. Prev. 2001 25 262 267.
12. Selim A, El-Ayat G, Wells C. Expression of c-erbB-2, p53, Bcl-2, Bax, c-myc and ki-67 in apocrine metaplasia and apocrine change within sclerosing adenosis of the breast. Virchows Arch. 2002 441 449 455.
13. Selim A, El-Ayat G, Naase M, Wells C. C-myc oncoprotein expression and gene amplification in apocrine change within sclerosing adenosis of the breast. The Breast 2002 11 466 472.
14. Selim A, Ryan A, El-Ayat G, Wells C. Loss of heterozygosity and allelic imbalance in apocrine metaplasia of the breast: microdissection microsatellite analysis. J. Pathol. 2002 196 287 291.
15. Hsu S-M, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled antibody (PAP) procedures. J. Histochem. Cytochem. 1981 29 577 580.
16. Norton A, Jordan S, Yeomans P. Brief, high-temperature heat denaturation (pressure cooking): a simple and effective method of antigen retrieval for routinely processed tissues. J. Pathol. 1994 173 371 379.
17. Fredersdorf S, Milne A, Hall P, Lu X. Characterization of a panel of novel anti-p21 monoclonal antibodies and immunohistochemical analysis of p21 expression in normal human tissues. Am. J. Pathol. 1996 148 825 835.
18. Nielsen G, Stemmer-Rachamimov A, Shaw J, Roy J, Koh R, Louis D. Immunohistochemical survey of p16 expression in normal human adult and infant tissues. Lab. Invest. 1999 79 1137 1143.
19. Catzavelos C, Bhattacharya N, Ung YC et al. Decreased levels of the cell cycle inhibitor p27 protein; prognostic implications in primary breast cancer. Nature Med. 1997 3 227 230.
20. Gillett C, Smith P, Peters G, Lu X, Barnes D. Cyclin dependent kinase inhibitor p27 expression and interaction with other cell cycle associated proteins in mammary carcinoma. J. Pathol. 1999 187 200 206.
21. Leong A, Hanby A, Potts H et al. Cell cycle proteins do not predict outcome in grade I infiltrating ductal carcinoma of the breast. Int. J. Cancer 2000 89 26 31.
22. Mommers E, Diest P, Leonhart A, Meijer C, Baak J. Expression of proliferation and apoptosis related proteins in usual ductal hyperplasia of the breast. Hum. Pathol. 1998 29 1539 1545.
23. Nielsen N, Emdin S, Cajander J, Landberg G. Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein. Oncogene 1997 14 295 304.
24. Ioffe O, Iskander M, Rucker C, Silverberg SG. Benign, malignant and pseudo-malignant apocrine lesions of the breast: another attempt at differential diagnosis. Lab. Invest. 1999 79 22A.
25. Ioffe O, Iskander M, Rucker C, Silverberg SG. A comparative study of c-erbB-2, p27, bcl-2 and Ki-67 expression in apocrine proliferations and benign breast tissue. Lab. Invest. 1999 79 22A.
26. Moriya T, Sakamoto K, Sasano H et al. Immunohistochemical analysis of Ki-67, p53, p21 and p27 in benign and malignant apocrine lesions of the breast: its correlation to histologic findings in 43 cases. Mod. Pathol. 2000 13 13 18.
27. Agnantis N, Mahera H, Maounis N, Spandidos D. Immunohistochemical study of ras and myc oncoproteins in apocrine breast lesions with and without papillomatosis. Eur. J. Gynaecol. Oncol. 1992 13 309 315.